+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hyper Personalized Medicine Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Product, Application, End-User, Region, By Country: 2020-2030

  • PDF Icon

    Report

  • 311 Pages
  • May 2024
  • Region: Global
  • Azoth Analytics
  • ID: 5971364
This report highlights different factors and opportunities prevailing in the “Global Hyper Personalized Medicine Market (2024 Edition)”. According to the report, Global Hyper Personalized Medicine Market registered market value of around USD 5.5 Trillion in 2023 is expected to grow at a CAGR of 12% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation By Product (Medicine Diagnostics, Medicine Therapeutics, Medical Care, Nutrition and Wellness and Other Product Types), By Application (Oncology, Diabetes, Cardiology, and Other Applications) and by End-User (Hospitals & Diagnostic Centers, Research and Academic Institutes).

Market Overview

Hyper-personalized medicine represents the forefront of medical innovation, where treatments are tailored specifically to individual patients based on their genetic makeup, environment, lifestyle, and even digital health data. This field leverages advancements in genomics, biotechnology, and data analytics to create precise and effective treatment options that are designed to work optimally for each unique individual.

Several factors are driving the growth of the hyper-personalized medicine market. Primarily, the increasing burden of chronic diseases and cancer across the globe calls for more effective treatment paradigms. Traditional one-size-fits-all treatments often fail to yield desired outcomes for all patients due to genetic and environmental variability. Hyper-personalized medicine promises higher efficacy and fewer side effects, addressing this unmet need.

Furthermore, the growing aging population worldwide increases the demand for more effective and personalized healthcare solutions. As people live longer, they seek treatments that are not only effective but also minimally invasive and tailored to their specific health conditions and genetic profiles.

Advances in technology and decreasing costs of genetic testing are making hyper-personalized approaches more accessible. The integration of electronic health records (EHRs) with genetic information is facilitating this trend, enabling more precise patient management and monitoring.Innovative technologies are continuously shaping the hyper-personalized medicine landscape. CRISPR and other gene-editing technologies offer potential for not just treating but also potentially curing genetic disorders by directly modifying the DNA. Wearable health technology and mobile health apps are enabling continuous monitoring of health status and real-time data collection, further enhancing the personalization of care.

Looking to the future, the integration of global health data networks could revolutionize hyper-personalized medicine by enabling the analysis of health data on a scale previously unimaginable. This could lead to breakthroughs in understanding complex diseases and developing treatments.

3D printing of drugs and bioprinting of tissues and organs are on the horizon, potentially allowing for therapies that are not only genetically but anatomically personalized. As 3D printing technology advances, it could become possible to manufacture bespoke drugs that are designed to release exactly the right dose at the right time for an individual's specific physiology.

Segment Insights

By Product, Nutrition and Wellness accounts for approximately 30% market share in 2023. Increasing health consciousness among consumers and the rising prevalence of chronic diseases such as obesity, diabetes, and cardiovascular diseases are significant drivers. These conditions are often linked to lifestyle and dietary habits, and personalized nutrition offers a proactive approach to prevention and management. Aging populations worldwide also contribute to market growth, as older adults seek lifestyle interventions to maintain health and vitality. Furthermore, the wellness industry has seen a shift towards prevention rather than treatment, with individuals increasingly willing to invest in health-enhancing products and services tailored to their specific needs.

Geographical Insights

Americas is the largest region in the Global Hyper Personalized Medicine Market . The primary driver of growth in hyper-personalized medicine across the Americas is technological advancement. High-throughput sequencing technologies, artificial intelligence (AI), and big data analytics have dramatically reduced the costs and increased the speed of genetic sequencing, making it feasible to consider genetic data in routine medical care. These technological strides have been complemented by significant investments in research and development by both public institutions and private enterprises, keen on uncovering novel therapeutic targets and tailoring treatments to individual genetic profiles.
Moreover, there is a growing awareness and acceptance of personalized medicine among healthcare providers and patients, fueled by the increasing availability of personalized treatment options and success stories in areas like oncology, where genetically targeted therapies have significantly improved outcomes. The regulatory landscape across the Americas is also adapting, with agencies like the U.S. Food and Drug Administration (FDA) accelerating approvals for personalized medicines and related diagnostics.

Market Segmentation

By Product:

  • Medicine Diagnostics
  • Medicine Therapeutics
  • Medical Care
  • Nutrition and Wellness
  • Other Products

By Application:

  • Oncology
  • Diabetes
  • Cardiology
  • Other Applications

By End-User:

  • Hospitals & Diagnostic Centers
  • Research and Academic Institutes

By Geography:

  • Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
  • Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new Product development and market share portfolio of top 15 companies. Key companies in the Global Hyper Personalized Medicine Market include:
  • QIAGEN
  • Danaher Corporation (Cepheid, Inc.)
  • Illumina, Inc.
  • GE Healthcare
  • Exagen Inc.
  • Abbott
  • Exact Sciences Corporation
  • Dako A/S
  • Decode Genetics, Inc.
  • ASURAGEN, INC.
  • Other Leading Companies

Reasons to buy this report:

  • In-Depth Comparative Assessment of Top 20 Markets in the Product Industry: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
  • Comprehensive Historical, Present, and Future Analytics of the Hyper Personalized Medicine Market : A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Hyper Personalized Medicine Market .
  • Detailed Analysis of Hyper Personalized Medicine Market By Product, Application, and End-User Across 20 Countries
  • Beyond the Purchase: 90 Days of Support
  • Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
  • Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
  • Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
  • Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
  • Strategic Industry Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies


This product will be delivered within 2 business days.

Table of Contents

1. Market Background
1.1 Scope and Service Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
3. Global Hyper Personalized Medicine Market : Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Hyper Personalized Medicine Market
3.2 Global Prevalence of Hyper Personalized Medicine (% of overall medicines)
3.3 Hyper Personalized Medicine Hyper Personalized Medicine Pipeline
3.4 Global Hyper Personalized Medicine Market : Dashboard
3.5 Global Hyper Personalized Medicine Market : Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
3.6 Global Hyper Personalized Medicine Market : Market Size and CAGR, By Volume, 2020-2030 (Number of Drugs) & CAGR)
3.7 Global Hyper Personalized Medicine Market : Market Value Assessment
3.8 Assessment of Degree of Impact of COVID-19 on Global Hyper Personalized Medicine Market
3.9 Global Hyper Personalized Medicine Market Segmentation : By Product
3.9.1 Global Hyper Personalized Medicine Market , By Product Overview
3.9.2 Global Hyper Personalized Medicine Market Attractiveness Index, By Product (2025-2030)
3.9.3 Global Hyper Personalized Medicine Market Size, By Medicine Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.4 Global Hyper Personalized Medicine Market Size, By Medicine Therapeutics, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.5 Global Hyper Personalized Medicine Market Size, By Medical Care, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.6 Global Hyper Personalized Medicine Market Size, By Nutrition and Wellness, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.7 Global Hyper Personalized Medicine Market Size, By Other Products, By Value, 2020H-2030F (USD Billion & CAGR)
3.10 Global Hyper Personalized Medicine Market Segmentation : By Application
3.10.1 Global Hyper Personalized Medicine Market , By Application Overview
3.10.2 Global Hyper Personalized Medicine Market Attractiveness Index, By Application (2025-2030)
3.10.3 Global Hyper Personalized Medicine Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.4 Global Hyper Personalized Medicine Market Size, By Diabetes, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.5 Global Hyper Personalized Medicine Market Size, By Cardiology, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.6 Global Hyper Personalized Medicine Market Size, By Other Applications, By Value, 2020H-2030F (USD Billion & CAGR)
3.11 Global Hyper Personalized Medicine Market Segmentation : By End-User
3.11.1 Global Hyper Personalized Medicine Market , By End-User Overview
3.11.2 Global Hyper Personalized Medicine Market Attractiveness Index, By End-User (2025-2030)
3.11.3 Global Hyper Personalized Medicine Market Size, By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.4 Global Hyper Personalized Medicine Market Size, By Research and Academic Institutes, By Value, 2020H-2030F (USD Billion & CAGR)
4. Hyper Personalized Medicine Market , Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Hyper Personalized Medicine Market : Historic and Forecast
5.1 Americas Hyper Personalized Medicine Market : Snapshot
5.2 Americas Hyper Personalized Medicine Market : Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
5.3 Americas Hyper Personalized Medicine Market : Market Size and CAGR, By Volume, 2020-2030 (Number of Drugs) & CAGR)
5.4 Americas Hyper Personalized Medicine Market : Key Factors
5.5 Americas Hyper Personalized Medicine Market : Segment Analysis
5.6 Americas Hyper Personalized Medicine Market Segmentation : By Product
5.6.1 Americas Hyper Personalized Medicine Market , By Product Overview
5.6.2 Americas Hyper Personalized Medicine Market Size, By Medicine Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Hyper Personalized Medicine Market Size, By Medicine Therapeutics, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Hyper Personalized Medicine Market Size, By Medical Care, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.5 Americas Hyper Personalized Medicine Market Size, By Nutrition and Wellness, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.6 Americas Hyper Personalized Medicine Market Size, By Other Products, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Hyper Personalized Medicine Market Segmentation : By Application
5.7.1 Americas Hyper Personalized Medicine Market , By Application Overview
5.7.2 Americas Hyper Personalized Medicine Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.3 Americas Hyper Personalized Medicine Market Size, By Diabetes, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.4 Americas Hyper Personalized Medicine Market Size, By Cardiology, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.5 Americas Hyper Personalized Medicine Market Size, By Other Applications, By Value, 2020H-2030F (USD Billion & CAGR)
5.8 Americas Hyper Personalized Medicine Market Segmentation : By End-User
5.8.1 Americas Hyper Personalized Medicine Market , By End-User Overview
5.8.2 Americas Hyper Personalized Medicine Market Size, By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billion & CAGR)
5.8.3 Americas Hyper Personalized Medicine Market Size, By Research and Academic Institutes, By Value, 2020H-2030F (USD Billion & CAGR)
5.9 Americas Hyper Personalized Medicine Market Segmentation : By Country
5.9.1 Americas Hyper Personalized Medicine Market , by Country Overview
5.9.2 United States Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.2.1 United States Hyper Personalized Medicine Market , By Product
5.9.2.2 United States Hyper Personalized Medicine Market , By Application
5.9.2.3 United States Hyper Personalized Medicine Market , By End-User
5.9.3 Canada Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.3.1 Canada Hyper Personalized Medicine Market , By Product
5.9.3.2 Canada Hyper Personalized Medicine Market , By Application
5.9.3.3 Canada Hyper Personalized Medicine Market , By End-User
5.9.4 Brazil Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.4.1 Brazil Hyper Personalized Medicine Market , By Product
5.9.4.2 Brazil Hyper Personalized Medicine Market , By Application
5.9.4.3 Brazil Hyper Personalized Medicine Market , By End-User
5.9.5 Mexico Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.5.1 Mexico Hyper Personalized Medicine Market , By Product
5.9.5.2 Mexico Hyper Personalized Medicine Market , By Application
5.9.5.3 Mexico Hyper Personalized Medicine Market , By End-User
5.9.6 Rest of Americas Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.9.6.1 Rest of Americas Hyper Personalized Medicine Market , By Product
5.9.6.2 Rest of Americas Hyper Personalized Medicine Market , By Application
5.9.6.3 Rest of Americas Hyper Personalized Medicine Market , By End-User
6. Europe Hyper Personalized Medicine Market : Historic and Forecast
6.1 Europe Hyper Personalized Medicine Market : Snapshot
6.2 Europe Hyper Personalized Medicine Market : Market Size and CAGR, BY Value, 2020-2030 (USD Billion & CAGR)
6.3 Europe Hyper Personalized Medicine Market : Market Size and CAGR, By Volume, 2020-2030 (Number of Drugs) & CAGR)
6.4 Europe Hyper Personalized Medicine Market : Key Factors
6.5 Europe Hyper Personalized Medicine Market : Segment Analysis
6.6 Europe Hyper Personalized Medicine Market Segmentation : By Product
6.6.1 Europe Hyper Personalized Medicine Market , By Product Overview
6.6.2 Europe Hyper Personalized Medicine Market Size, By Medicine Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Hyper Personalized Medicine Market Size, By Medicine Therapeutics, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.4 Europe Hyper Personalized Medicine Market Size, By Medical Care, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.5 Europe Hyper Personalized Medicine Market Size, By Nutrition and Wellness, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.6 Europe Hyper Personalized Medicine Market Size, By Other Products, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Hyper Personalized Medicine Market Segmentation : By Application
6.7.1 Europe Hyper Personalized Medicine Market , By Application Overview
6.7.2 Europe Hyper Personalized Medicine Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.3 Europe Hyper Personalized Medicine Market Size, By Diabetes, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.4 Europe Hyper Personalized Medicine Market Size, By Cardiology, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.5 Europe Hyper Personalized Medicine Market Size, By Other Applications, By Value, 2020H-2030F (USD Billion & CAGR)
6.8 Europe Hyper Personalized Medicine Market Segmentation : By End-User
6.8.1 Europe Hyper Personalized Medicine Market , By End-User Overview
6.8.2 Europe Hyper Personalized Medicine Market Size, By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billion & CAGR)
6.8.3 Europe Hyper Personalized Medicine Market Size, By Research and Academic Institutes, By Value, 2020H-2030F (USD Billion & CAGR)
6.9 Europe Hyper Personalized Medicine Market Segmentation : By Country
6.9.1 Europe Hyper Personalized Medicine Market , by Country Overview
6.9.2 Russia Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.2.1 Russia Hyper Personalized Medicine Market , By Product
6.9.2.2 Russia Hyper Personalized Medicine Market , By Application
6.9.2.3 Russia Hyper Personalized Medicine Market , By End-User
6.9.3 France Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.3.1 France Hyper Personalized Medicine Market , By Product
6.9.3.2 France Hyper Personalized Medicine Market , By Application
6.9.3.3 France Hyper Personalized Medicine Market , By End-User
6.9.4 United Kingdom Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.4.1 United Kingdom Hyper Personalized Medicine Market , By Product
6.9.4.2 United Kingdom Hyper Personalized Medicine Market , By Application
6.9.4.3 United Kingdom Hyper Personalized Medicine Market , By End-User
6.9.5 Germany Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.5.1 Germany Hyper Personalized Medicine Market , By Product
6.9.5.2 Germany Hyper Personalized Medicine Market , By Application
6.9.5.3 Germany Hyper Personalized Medicine Market , By End-User
6.9.6 Italy Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.6.1 Italy Hyper Personalized Medicine Market , By Product
6.9.6.2 Italy Hyper Personalized Medicine Market , By Application
6.9.6.3 Italy Hyper Personalized Medicine Market , By End-User
6.9.7 Spain Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.7.1 Spain Hyper Personalized Medicine Market , By Product
6.9.7.2 Spain Hyper Personalized Medicine Market , By Application
6.9.7.3 Spain Hyper Personalized Medicine Market , By End-User
6.9.8 Turkey Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.8.1 Turkey Hyper Personalized Medicine Market , By Product
6.9.8.2 Turkey Hyper Personalized Medicine Market , By Application
6.9.8.3 Turkey Hyper Personalized Medicine Market , By End-User
6.9.9 Rest of Europe Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.9.9.1 Rest of Europe Hyper Personalized Medicine Market , By Product
6.9.9.2 Rest of Europe Hyper Personalized Medicine Market , By Application
6.9.9.3 Rest of Europe Hyper Personalized Medicine Market , By End-User
7. Asia Pacific Hyper Personalized Medicine Market : Historic and Forecast
7.1 Asia Pacific Hyper Personalized Medicine Market : Snapshot
7.2 Asia Pacific Hyper Personalized Medicine Market : Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Hyper Personalized Medicine Market : Market Size and CAGR, By Volume, 2020-2030 (Number of Drugs) & CAGR)
7.4 Asia Pacific Hyper Personalized Medicine Market : Key Factors
7.5 Asia Pacific Hyper Personalized Medicine Market : Segment Analysis
7.6 Asia Pacific Hyper Personalized Medicine Market Segmentation : By Product
7.6.1 Asia Pacific Hyper Personalized Medicine Market , By Product Overview
7.6.2 Asia Pacific Hyper Personalized Medicine Market Size, By Medicine Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Hyper Personalized Medicine Market Size, By Medicine Therapeutics, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.4 Asia Pacific Hyper Personalized Medicine Market Size, By Medical Care, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.5 Asia Pacific Hyper Personalized Medicine Market Size, By Nutrition and Wellness, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.6 Asia Pacific Hyper Personalized Medicine Market Size, By Other Products, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Hyper Personalized Medicine Market Segmentation : By Application
7.7.1 Asia Pacific Hyper Personalized Medicine Market , By Application Overview
7.7.2 Asia Pacific Hyper Personalized Medicine Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.3 Asia Pacific Hyper Personalized Medicine Market Size, By Diabetes, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.4 Asia Pacific Hyper Personalized Medicine Market Size, By Cardiology, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.5 Asia Pacific Hyper Personalized Medicine Market Size, By Other Applications, By Value, 2020H-2030F (USD Billion & CAGR)
7.8 Asia Pacific Hyper Personalized Medicine Market Segmentation : By End-User
7.8.1 Asia Pacific Hyper Personalized Medicine Market , By End-User Overview
7.8.2 Asia Pacific Hyper Personalized Medicine Market Size, By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billion & CAGR)
7.8.3 Asia Pacific Hyper Personalized Medicine Market Size, By Research and Academic Institutes, By Value, 2020H-2030F (USD Billion & CAGR)
7.9 Asia Pacific Hyper Personalized Medicine Market Segmentation : By Country
7.9.1 Asia Pacific Hyper Personalized Medicine Market , by Country Overview
7.9.2 China Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.2.1 China Hyper Personalized Medicine Market , By Product
7.9.2.2 China Hyper Personalized Medicine Market , By Application
7.9.2.3 China Hyper Personalized Medicine Market , By End-User
7.9.3 India Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.3.1 India Hyper Personalized Medicine Market , By Product
7.9.3.2 India Hyper Personalized Medicine Market , By Application
7.9.3.3 India Hyper Personalized Medicine Market , By End-User
7.9.4 South Korea Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.4.1 South Korea Hyper Personalized Medicine Market , By Product
7.9.4.2 South Korea Hyper Personalized Medicine Market , By Application
7.9.4.3 South Korea Hyper Personalized Medicine Market , By End-User
7.9.5 Japan Korea Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.5.1 Japan Hyper Personalized Medicine Market , By Product
7.9.5.2 Japan Hyper Personalized Medicine Market , By Application
7.9.5.3 Japan Hyper Personalized Medicine Market , By End-User
7.9.6 Singapore Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.6.1 Singapore Hyper Personalized Medicine Market , By Product
7.9.6.2 Singapore Hyper Personalized Medicine Market , By Application
7.9.6.3 Singapore Hyper Personalized Medicine Market , By End-User
7.9.7 Indonesia Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.7.1 Indonesia Hyper Personalized Medicine Market , By Product
7.9.7.2 Indonesia Hyper Personalized Medicine Market , By Application
7.9.7.3 Indonesia Hyper Personalized Medicine Market , By End-User
7.9.8 Rest of Asia Pacific Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.9.8.1 Rest of Asia Pacific Hyper Personalized Medicine Market , By Product
7.9.8.2 Rest of Asia Pacific Hyper Personalized Medicine Market , By Application
7.9.8.3 Rest of Asia Pacific Hyper Personalized Medicine Market , By End-User
8. Middle East & Africa Hyper Personalized Medicine Market : Historic and Forecast
8.1 Middle East & Africa Hyper Personalized Medicine Market : Snapshot
8.2 Middle East & Africa Hyper Personalized Medicine Market : Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
8.3 Middle East & Africa Hyper Personalized Medicine Market : Market Size and CAGR, By Volume, 2020-2030 (Number of Drugs) & CAGR)
8.4 Middle East & Africa Hyper Personalized Medicine Market : Key Factors
8.5 Middle East and Africa Hyper Personalized Medicine Market : Segment Analysis
8.6 Middle East & Africa Hyper Personalized Medicine Market Segmentation : By Product
8.6.1 Middle East & Africa Hyper Personalized Medicine Market , By Product Overview
8.6.2 Middle East & Africa Hyper Personalized Medicine Market Size, By Medicine Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East & Africa Hyper Personalized Medicine Market Size, By Medicine Therapeutics, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.4 Middle East & Africa Hyper Personalized Medicine Market Size, By Medical Care, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.5 Middle East & Africa Hyper Personalized Medicine Market Size, By Nutrition and Wellness, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.6 Middle East & Africa Hyper Personalized Medicine Market Size, By Other Products, By Value, 2020H-2030F (USD Billion & CAGR)
8.7 Middle East & Africa Hyper Personalized Medicine Market Segmentation : By Application
8.7.1 Middle East & Africa Hyper Personalized Medicine Market, By Application Overview
8.7.2 Middle East & Africa Hyper Personalized Medicine Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.3 Middle East & Africa Hyper Personalized Medicine Market Size, By Diabetes, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.4 Middle East & Africa Hyper Personalized Medicine Market Size, By Cardiology, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.5 Middle East & Africa Hyper Personalized Medicine Market Size, By Other Applications, By Value, 2020H-2030F (USD Billion & CAGR)
8.8 Middle East & Africa Hyper Personalized Medicine Market Segmentation : By End-User
8.8.1 Middle East & Africa Hyper Personalized Medicine Market , By End-User Overview
8.8.2 Middle East & Africa Hyper Personalized Medicine Market Size, By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billion & CAGR)
8.8.3 Middle East & Africa Hyper Personalized Medicine Market Size, By Research and Academic Institutes, By Value, 2020H-2030F (USD Billion & CAGR)
8.8.4 Middle East & Africa Hyper Personalized Medicine Market , by Country Overview
8.8.5 GCC Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.5.1 GCC Hyper Personalized Medicine Market , By Product
8.8.5.2 GCC Hyper Personalized Medicine Market , By Application
8.8.5.3 GCC Hyper Personalized Medicine Market , By End-User
8.8.6 Israel Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.6.1 Israel Hyper Personalized Medicine Market , By Product
8.8.6.2 Israel Hyper Personalized Medicine Market , By Application
8.8.6.3 Israel Hyper Personalized Medicine Market , By End-User
8.8.7 South Africa Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.7.1 South Africa Hyper Personalized Medicine Market , By Product
8.8.7.2 South Africa Hyper Personalized Medicine Market , By Application
8.8.7.3 South Africa Hyper Personalized Medicine Market , By End-User
8.8.8 Rest of Middle East and Africa Hyper Personalized Medicine Market : Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.8.1 Rest of Middle East and Africa Hyper Personalized Medicine Market , By Product
8.8.8.2 Rest of Middle East and Africa Hyper Personalized Medicine Market , By Application
8.8.8.3 Rest of Middle East and Africa Hyper Personalized Medicine Market , By End-User
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Hyper Personalized Medicine Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Service Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Hyper Personalized Medicine Market
11.4 Company Profiles
11.4.1. QIAGEN
11.4.2. Danaher Corporation (Cepheid, Inc.)
11.4.3. Illumina, Inc.
11.4.4. GE Healthcare
11.4.5. Exagen Inc.
11.4.6. Abbott
11.4.7. Exact Sciences Corporation
11.4.8. Dako A/S
11.4.9. Decode Genetics, Inc.
11.4.10. ASURAGEN, INC.
11.4.11. Other Leading Companies
12. About the Publisher & Disclaimer
List of Figures
Figure 1: Prevalence of Hyper Personalized Medicine (% of overall medicines), 2023 (%)
Figure 2: Prevalence of Hyper Personalized Medicine (% of overall medicines), 2030 (%)
Figure 3: Hyper Personalized Medicine Pipeline
Figure 4: Hyper Personalized Medicine Demand Analysis
Figure 5: Global Hyper Personalized Medicine Market Size, By Value, 2020-2023 (USD Billion)
Figure 6: Global Hyper Personalized Medicine Market Size, By Value, 2024-2030 (USD Billion)
Figure 7: Global Hyper Personalized Medicine Market Share, By Application, 2023 (%)
Figure 8: Global Hyper Personalized Medicine Market Size, By Volume, 2020-2023 (Number of Drugs)
Figure 9: Global Hyper Personalized Medicine Market Size, By Volume, 2024-2030 (Number of Drugs)
Figure 10: Global Hyper Personalized Medicine Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Hyper Personalized Medicine Market , By Product (2025-2030)
Figure 12: Global Hyper Personalized Medicine Market Size, By Medicine Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 13: Global Hyper Personalized Medicine Market Absolute Opportunity, By Medicine Diagnostics, 2020-2030 (USD Billion)
Figure 14: Global Hyper Personalized Medicine Market Size, By Medicine Therapeutics, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 15: Global Hyper Personalized Medicine Market Absolute Opportunity, By Medicine Therapeutics, 2020-2030 (USD Billion)
Figure 16: Global Hyper Personalized Medicine Market Size, By Medical Care, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 17: Global Hyper Personalized Medicine Market Absolute Opportunity, By Medical Care, 2020-2030 (USD Billion)
Figure 18: Global Hyper Personalized Medicine Market Size, By Nutrition and Wellness, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 19: Global Hyper Personalized Medicine Market Absolute Opportunity, By Nutrition and Wellness, 2020-2030 (USD Billion)
Figure 20: Global Hyper Personalized Medicine Market Size, By Other Products, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 21: Global Hyper Personalized Medicine Market Absolute Opportunity, By Other Products, 2020-2030 (USD Billion)
Figure 22: Market Attractiveness Analysis of Global Hyper Personalized Medicine Market , By Application (2025-2030)
Figure 23: Global Hyper Personalized Medicine Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 24: Global Hyper Personalized Medicine Market Absolute Opportunity, By Oncology, 2020-2030 (USD Billion)
Figure 25: Global Hyper Personalized Medicine Market Size, By Diabetes, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 26: Global Hyper Personalized Medicine Market Absolute Opportunity, By Diabetes, 2020-2030 (USD Billion)
Figure 27: Global Hyper Personalized Medicine Market Size, By Cardiology, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 28: Global Hyper Personalized Medicine Market Absolute Opportunity, By Cardiology, 2020-2030 (USD Billion)
Figure 29: Global Hyper Personalized Medicine Market Size, By Other Applications, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 30: Global Hyper Personalized Medicine Market Absolute Opportunity, By Other Applications, 2020-2030 (USD Billion)
Figure 31: Market Attractiveness Analysis of Global Hyper Personalized Medicine Market , By End-User (2025-2030)
Figure 32: Global Hyper Personalized Medicine Market Size, By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 33: Global Hyper Personalized Medicine Market Absolute Opportunity, By Hospitals & Diagnostic Centers, 2020-2030 (USD Billion)
Figure 34: Global Hyper Personalized Medicine Market Size, By Research and Academic Institutes, By Value, 2020H-2030F (USD Billion & CAGR)
Figure 35: Global Hyper Personalized Medicine Market Absolute Opportunity, By Research and Academic Institutes, 2020-2030 (USD Billion)
Figure 36: Americas Hyper Personalized Medicine Market Size, By Value, 2020H-2030F (USD Billion)
Figure 37: Americas Hyper Personalized Medicine Market Share, By Application, 2023 (%)
Figure 38: Americas Hyper Personalized Medicine Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 39: Americas Hyper Personalized Medicine Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 40: Americas Hyper Personalized Medicine Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 41: Americas Hyper Personalized Medicine Market , By Medicine Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 42: Americas Hyper Personalized Medicine Market , By Medicine Therapeutics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 43: Americas Hyper Personalized Medicine Market , By Medical Care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 44: Americas Hyper Personalized Medicine Market , By Nutrition and Wellness, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 45: Americas Hyper Personalized Medicine Market , By Other Products, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 46: Americas Hyper Personalized Medicine Market , By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 47: Americas Hyper Personalized Medicine Market , By Diabetes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 48: Americas Hyper Personalized Medicine Market , By Cardiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 49: Americas Hyper Personalized Medicine Market , By Other Applications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 50: Americas Hyper Personalized Medicine Market , By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 51: Americas Hyper Personalized Medicine Market , By Research and Academic Institutes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 52: United States Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 53: United States Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 54: United States Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 55: United States Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 56: United States Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 57: Canada Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 58: Canada Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 59: Canada Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 60: Canada Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 61: Canada Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 62: Brazil Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 63: Brazil Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 64: Brazil Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 65: Brazil Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 66: Brazil Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 67: Mexico Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 68: Mexico Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 69: Mexico Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 70: Mexico Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 71: Mexico Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 72: Rest of Americas Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 73: Rest of Americas Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 74: Rest of Americas Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 75: Rest of Americas Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 76: Rest of Americas Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 77: Europe Hyper Personalized Medicine Market Size, By Value, 2020H-2030F (USD Billion)
Figure 78: Europe Hyper Personalized Medicine Market Share, By Application, 2023 (%)
Figure 79: Europe Hyper Personalized Medicine Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 80: Europe Hyper Personalized Medicine Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 81: Europe Hyper Personalized Medicine Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 82: Europe Hyper Personalized Medicine Market , By Medicine Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 83: Europe Hyper Personalized Medicine Market , By Medicine Therapeutics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 84: Europe Hyper Personalized Medicine Market , By Medical Care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 85: Europe Hyper Personalized Medicine Market , By Nutrition and Wellness, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 86: Europe Hyper Personalized Medicine Market , By Other Products, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 87: Europe Hyper Personalized Medicine Market , By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 88: Europe Hyper Personalized Medicine Market , By Diabetes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 89: Europe Hyper Personalized Medicine Market , By Cardiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 90: Europe Hyper Personalized Medicine Market , By Other Applications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 91: Europe Hyper Personalized Medicine Market , By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 92: Europe Hyper Personalized Medicine Market , By Research and Academic Institutes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 93: Russia Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 94: Russia Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 95: Russia Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 96: Russia Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 97: Russia Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 98: France Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 99: France Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 100: France Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 101: France Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 102: France Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 103: United Kingdom Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 104: United Kingdom Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 105: United Kingdom Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 106: United Kingdom Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 107: United Kingdom Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 108: Germany Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 109: Germany Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 110: Germany Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 111: Germany Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 112: Germany Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 113: Italy Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 114: Italy Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 115: Italy Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 116: Italy Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 117: Italy Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 118: Spain Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 119: Spain Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 120: Spain Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 121: Spain Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 122: Spain Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 123: Turkey Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 124: Turkey Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 125: Turkey Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 126: Turkey Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 127: Turkey Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 128: Rest of Europe Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 129: Rest of Europe Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 130: Rest of Europe Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 131: Rest of Europe Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 132: Rest of Europe Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 133: Asia Pacific Hyper Personalized Medicine Market Size, By Value, 2020H-2030F (USD Billion)
Figure 134: Asia Pacific Hyper Personalized Medicine Market Share, By Application, 2023 (%)
Figure 135: Asia Pacific Hyper Personalized Medicine Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 136: Asia Pacific Hyper Personalized Medicine Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 137: Asia Pacific Hyper Personalized Medicine Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 138: Asia Pacific Hyper Personalized Medicine Market , By Medicine Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 139: Asia Pacific Hyper Personalized Medicine Market , By Medicine Therapeutics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 140: Asia Pacific Hyper Personalized Medicine Market , By Medical Care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 141: Asia Pacific Hyper Personalized Medicine Market , By Nutrition and Wellness, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 142: Asia Pacific Hyper Personalized Medicine Market , By Other Products, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 143: Asia Pacific Hyper Personalized Medicine Market , By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 144: Asia Pacific Hyper Personalized Medicine Market , By Diabetes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 145: Asia Pacific Hyper Personalized Medicine Market , By Cardiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 146: Asia Pacific Hyper Personalized Medicine Market , By Other Applications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 147: Asia Pacific Hyper Personalized Medicine Market , By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 148: Asia Pacific Hyper Personalized Medicine Market , By Research and Academic Institutes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 149: China Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 150: China Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 151: China Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 152: China Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 153: China Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 154: India Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 155: India Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 156: India Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 157: India Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 158: India Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 159: South Korea Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 160: South Korea Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 161: South Korea Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 162: South Korea Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 163: South Korea Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 164: Japan Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 165: Japan Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 166: Japan Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 167: Japan Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 168: Japan Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 169: Singapore Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 170: Singapore Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 171: Singapore Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 172: Singapore Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 173: Singapore Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 174: Indonesia Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 175: Indonesia Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 176: Indonesia Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 177: Indonesia Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 178: Indonesia Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 180: Rest of Asia Pacific Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 181: Rest of Asia Pacific Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 184: Middle East and Africa Hyper Personalized Medicine Market Size, By Value, 2020H-2030F (USD Billion)
Figure 185: Middle East and Africa Hyper Personalized Medicine Market Share, By Application, 2023 (%)
Figure 186: Middle East and Africa Hyper Personalized Medicine Market Size, By Volume, 2020-2023 (in Number of Drugs)
Figure 187: Middle East and Africa Hyper Personalized Medicine Market Size, By Volume, 2024-2030 (in Number of Drugs)
Figure 188: Middle East and Africa Hyper Personalized Medicine Market CAGR (%), By Volume, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Hyper Personalized Medicine Market , By Medicine Diagnostics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 190: Middle East and Africa Hyper Personalized Medicine Market , By Medicine Therapeutics, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 191: Middle East and Africa Hyper Personalized Medicine Market , By Medical Care, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 192: Middle East and Africa Hyper Personalized Medicine Market , By Nutrition and Wellness, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 193: Middle East and Africa Hyper Personalized Medicine Market , By Other Products, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 194: Middle East and Africa Hyper Personalized Medicine Market , By Oncology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 195: Middle East and Africa Hyper Personalized Medicine Market , By Diabetes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 196: Middle East and Africa Hyper Personalized Medicine Market , By Cardiology, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 197: Middle East and Africa Hyper Personalized Medicine Market , By Other Applications, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 198: Middle East and Africa Hyper Personalized Medicine Market , By Hospitals & Diagnostic Centers, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 199: Middle East and Africa Hyper Personalized Medicine Market , By Research and Academic Institutes, By Value, 2020H-2030F (USD Billions & CAGR)
Figure 200: GCC Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 201: GCC Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 202: GCC Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 203: GCC Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 204: GCC Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 205: Israel Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 206: Israel Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 207: Israel Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 208: Israel Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 209: Israel Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 210: South Africa Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 211: South Africa Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 212: South Africa Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 213: South Africa Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 214: South Africa Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Hyper Personalized Medicine Market , By Value, 2020-2030 (USD Billion & CAGR)
Figure 216: Rest of Middle East and Africa Hyper Personalized Medicine Market Value, By End-User, 2023 (USD Billion)
Figure 217: Rest of Middle East and Africa Hyper Personalized Medicine Market Share, By Product, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Hyper Personalized Medicine Market Share, By Application, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Hyper Personalized Medicine Market Share, By End-User, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Hyper Personalized Medicine Market , 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A3: United States Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A4: United States Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A5: United States Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A6: United States Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A7: United States Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A8: Canada Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A9: Canada Hyper Personalized Medicine Market , By Product, By Value, 2024- 2030 (USD Billion)
Table A10: Canada Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A11: Canada Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A12: Canada Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A13: Canada Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A14: Brazil Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A15: Brazil Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A16: Brazil Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A17: Brazil Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A18: Brazil Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A19: Brazil Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A20: Mexico Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A21: Mexico Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A22: Mexico Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A23: Mexico Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A24: Mexico Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A25: Mexico Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A26: Rest of Americas Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A27: Rest of Americas Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A28: Rest of Americas Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A29: Rest of Americas Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A30: Rest of Americas Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A31: Rest of Americas Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A32: Russia Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A33: Russia Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A34: Russia Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A35: Russia Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A36: Russia Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A37: Russia Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A38: France Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A39: France Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A40: France Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A41: France Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A42: France Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A43: France Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A44: United Kingdom Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A45: United Kingdom Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A46: United Kingdom Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A47: United Kingdom Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A48: United Kingdom Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A49: United Kingdom Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A50: Germany Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A51: Germany Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A52: Germany Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A53: Germany Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A54: Germany Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A55: Germany Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A56: Italy Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A57: Italy Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A58: Italy Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A59: Italy Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A60: Italy Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A61: Italy Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A62: Spain Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A63: Spain Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A64: Spain Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A65: Spain Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A66: Spain Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A67: Spain Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A68: Turkey Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A69: Turkey Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A70: Turkey Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A71: Turkey Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A72: Turkey Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A73: Turkey Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A74: Rest of Europe Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A75: Rest of Europe Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A76: Rest of Europe Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A77: Rest of Europe Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A78: Rest of Europe Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A79: Rest of Europe Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A80: China Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A81: China Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A82: China Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A83: China Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A84: China Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A85: China Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A86: India Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A87: India Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A88: India Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A89: India Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A90: India Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A91: India Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A92: South Korea Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A93: South Korea Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A94: South Korea Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A95: South Korea Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A96: South Korea Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A97: South Korea Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A98: Japan Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A99: Japan Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A100: Japan Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A101: Japan Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A102: Japan Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A103: Japan Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A104: Singapore Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A105: Singapore Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A106: Singapore Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A107: Singapore Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A108: Singapore Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A109: Singapore Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A110: Indonesia Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A111: Indonesia Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A112: Indonesia Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A113: Indonesia Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A114: Indonesia Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A115: Indonesia Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A116: Rest of Asia Pacific Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A117: Rest of Asia Pacific Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A118: Rest of Asia Pacific Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A119: Rest of Asia Pacific Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A120: Rest of Asia Pacific Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A121: Rest of Asia Pacific Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A122: GCC Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A123: GCC Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A124: GCC Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A125: GCC Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A126: GCC Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A127: GCC Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A128: Israel Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A129: Israel Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A130: Israel Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A131: Israel Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A132: Israel Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A133: Israel Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A134: South Africa Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A135: South Africa Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A136: South Africa Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A137: South Africa Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A138: South Africa Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A139: South Africa Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)
Table A140: Rest of Middle East and Africa Hyper Personalized Medicine Market , By Product, By Value, 2020-2023 (USD Billion)
Table A141: Rest of Middle East and Africa Hyper Personalized Medicine Market , By Product, By Value, 2024-2030 (USD Billion)
Table A142: Rest of Middle East and Africa Hyper Personalized Medicine Market , By Application, By Value, 2020-2023 (USD Billion)
Table A143: Rest of Middle East and Africa Hyper Personalized Medicine Market , By Application, By Value, 2024-2030 (USD Billion)
Table A144: Rest of Middle East and Africa Hyper Personalized Medicine Market , By End-User, By Value, 2020-2023 (USD Billion)
Table A145: Rest of Middle East and Africa Hyper Personalized Medicine Market , By End-User, By Value, 2024-2030 (USD Billion)

Companies Mentioned

  • QIAGEN
  • Danaher Corporation (Cepheid, Inc.)
  • Illumina, Inc.
  • GE Healthcare
  • Exagen Inc.
  • Abbott
  • Exact Sciences Corporation
  • Dako A/S
  • Decode Genetics, Inc.
  • ASURAGEN, INC.